These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1849199)

  • 1. [Sashima epidemic hepatitis: epidemiological feature and anti-HCV status].
    Wakayama Y; Aramaki T
    Nihon Rinsho; 1991 Feb; 49(2):397-401. PubMed ID: 1849199
    [No Abstract]   [Full Text] [Related]  

  • 2. Second generation anti-HCV test: seroprevalence in hemodialysis patients and blood donors.
    Holzberger G; Seidl S; Peschke B; Scheuermann EH; Schoeppe W
    Transplant Proc; 1992 Dec; 24(6):2648-9. PubMed ID: 1334595
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevalence and significance of HCV infection in a consecutive series of patients with HBV antibodies and raised aminotransferases.
    Delle Monache M; Santolamazza M; Marinelli RM; Ricci GL
    Ital J Gastroenterol; 1991; 23(3):140-1. PubMed ID: 1660329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver biopsy is essential in anti-HCV (+) renal transplant patients irrespective of liver function tests and serology for HCV.
    Boletis J; Delladetsima J; Psimenou E; Vafiadi I; Tzala E; Katsoulidou A; Kostakis A; Hatzakis A; Vosnides G
    Transplant Proc; 1995 Feb; 27(1):945-7. PubMed ID: 7533439
    [No Abstract]   [Full Text] [Related]  

  • 5. [Anti-HCV-screening of blood donors in Gothenburg--the second generation tests are more specific].
    Lindholm A; Shev S; Norkrans G; Iwarson S; Hermodsson S
    Lakartidningen; 1991 Oct; 88(42):3475-6. PubMed ID: 1658502
    [No Abstract]   [Full Text] [Related]  

  • 6. [Serological study on hepatitis C (HCV) in 4371 blood donors].
    Arnone M; Pinducciu G; Usai M; Pitzus F; Pintus L
    Ann Ig; 1990; 2(5):353-8. PubMed ID: 1715726
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatitis C in kidney transplant patients.
    Oka T; Yasumura T
    Transplant Proc; 1996 Jun; 28(3):1163-7. PubMed ID: 8658612
    [No Abstract]   [Full Text] [Related]  

  • 8. [Epidemiological and clinical significance of HCV antibody--future problems].
    Nishioka K
    Nihon Rinsho; 1991 Feb; 49(2):267-72. PubMed ID: 1849181
    [No Abstract]   [Full Text] [Related]  

  • 9. Antibodies to hepatitis C virus (HCV) in chronic renal failure (CRF) patients on conservative therapy: prevalence, risk factors and relationship to liver disease.
    Fabrizi F; Marcelli D; Bacchini G; Guarnori I; Erba G; Locatelli F
    Nephrol Dial Transplant; 1994; 9(7):780-4. PubMed ID: 7526275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to hepatitis C virus and chronic hypertransaminasemia in southern Italy.
    Fiore G; Buongiorno G; Misciagna G; Napoli N; Quaranta G; Miccolis P; Guerra V; Giorgio I; Schiraldi O
    Ital J Gastroenterol; 1991; 23(3):138-9. PubMed ID: 1660328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expanding organ availability by using hepatitis C antibody positive donors.
    Aswad S; Mendez R; Weingart RG; Mendez R
    Transplant Proc; 1993 Jun; 25(3):2270-1. PubMed ID: 7685947
    [No Abstract]   [Full Text] [Related]  

  • 12. Antibody responses to hepatitis C virus and its modes of transmission in dialysis patients.
    Almroth G; Ekermo B; Franzén L; Hed J
    Nephron; 1991; 59(2):232-5. PubMed ID: 1659671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnosis and physiopathology of alcoholic liver diseases].
    Takada A
    Nihon Naika Gakkai Zasshi; 1992 Mar; 81(3):302-7. PubMed ID: 1318927
    [No Abstract]   [Full Text] [Related]  

  • 14. [Incidence of hepatitis C virus in kidney transplantation recipients].
    Catelle A; Edert D; Renoult E; Cao Huu T
    Agressologie; 1992; 33 Spec No 2():99-102. PubMed ID: 1340101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of hepatitis C antibodies in patients with clotting disorders in Victoria. Relationship with other blood borne viruses and liver disease.
    Leslie DE; Rann S; Nicholson S; Fairley CK; Gust ID
    Med J Aust; 1992 Jun; 156(11):789-92. PubMed ID: 1321326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Transaminases and histological activity in chronic hepatitis C].
    Zaugg PY; Bernardi M; Schmid M; Havelka J; Bühler H
    Schweiz Med Wochenschr; 1995 Apr; 125(15):719-22. PubMed ID: 7537891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of hepatitis C virus (HCV) RNA and anti-HCV results and evaluation of the relationship between transaminase levels].
    Kaşifoğlu N; Us T; Akgün Y
    Mikrobiyol Bul; 2007 Oct; 41(4):557-63. PubMed ID: 18173074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Even with normal transaminases the liver can be infected with HBV or HCV].
    Mauss S; Jablonowski H; Hüppe D
    MMW Fortschr Med; 2010 Apr; 152(17):62-4. PubMed ID: 20509266
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of anti-hepatitis C virus (HCV) antibody on outcomes in renal transplant recipients infected with HCV.
    Minz M; Sharma A; Das A; Chawla Y
    Transplant Proc; 2008 Sep; 40(7):2386-8. PubMed ID: 18790242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of hepatitis B virus markers for surrogate testing of hepatitis C].
    Ohto H; Nomura H; Ohmura K; Ishijima A; Okazaki S
    Rinsho Byori; 1991 Jan; 39(1):14-7. PubMed ID: 1848910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.